Overview

Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension
Details
Lead Sponsor:
Boehringer Ingelheim